rs41312901

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001735.3(C5):​c.4221-13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0637 in 1,581,644 control chromosomes in the GnomAD database, including 3,579 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.057 ( 293 hom., cov: 32)
Exomes 𝑓: 0.064 ( 3286 hom. )

Consequence

C5
NM_001735.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.48

Publications

6 publications found
Variant links:
Genes affected
C5 (HGNC:1331): (complement C5) This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
C5 Gene-Disease associations (from GenCC):
  • complement component 5 deficiency
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 9-120963751-A-G is Benign according to our data. Variant chr9-120963751-A-G is described in ClinVar as Benign. ClinVar VariationId is 402452.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0671 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C5NM_001735.3 linkc.4221-13T>C intron_variant Intron 33 of 40 ENST00000223642.3 NP_001726.2
C5NM_001317163.2 linkc.4239-13T>C intron_variant Intron 33 of 40 NP_001304092.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C5ENST00000223642.3 linkc.4221-13T>C intron_variant Intron 33 of 40 1 NM_001735.3 ENSP00000223642.1

Frequencies

GnomAD3 genomes
AF:
0.0572
AC:
8706
AN:
152200
Hom.:
292
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0600
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.0593
Gnomad ASJ
AF:
0.0628
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.0739
Gnomad FIN
AF:
0.0132
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0649
Gnomad OTH
AF:
0.0569
GnomAD2 exomes
AF:
0.0572
AC:
14151
AN:
247360
AF XY:
0.0574
show subpopulations
Gnomad AFR exome
AF:
0.0627
Gnomad AMR exome
AF:
0.0600
Gnomad ASJ exome
AF:
0.0650
Gnomad EAS exome
AF:
0.000829
Gnomad FIN exome
AF:
0.0153
Gnomad NFE exome
AF:
0.0692
Gnomad OTH exome
AF:
0.0588
GnomAD4 exome
AF:
0.0644
AC:
92028
AN:
1429326
Hom.:
3286
Cov.:
25
AF XY:
0.0645
AC XY:
46015
AN XY:
713010
show subpopulations
African (AFR)
AF:
0.0631
AC:
2050
AN:
32500
American (AMR)
AF:
0.0590
AC:
2631
AN:
44598
Ashkenazi Jewish (ASJ)
AF:
0.0619
AC:
1601
AN:
25876
East Asian (EAS)
AF:
0.000686
AC:
27
AN:
39378
South Asian (SAS)
AF:
0.0675
AC:
5758
AN:
85286
European-Finnish (FIN)
AF:
0.0167
AC:
892
AN:
53258
Middle Eastern (MID)
AF:
0.0628
AC:
359
AN:
5720
European-Non Finnish (NFE)
AF:
0.0692
AC:
74955
AN:
1083454
Other (OTH)
AF:
0.0634
AC:
3755
AN:
59256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
3676
7352
11028
14704
18380
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2808
5616
8424
11232
14040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0572
AC:
8714
AN:
152318
Hom.:
293
Cov.:
32
AF XY:
0.0551
AC XY:
4104
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0601
AC:
2498
AN:
41548
American (AMR)
AF:
0.0590
AC:
903
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0628
AC:
218
AN:
3472
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5190
South Asian (SAS)
AF:
0.0734
AC:
354
AN:
4826
European-Finnish (FIN)
AF:
0.0132
AC:
140
AN:
10624
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0650
AC:
4419
AN:
68036
Other (OTH)
AF:
0.0573
AC:
121
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
422
844
1267
1689
2111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0627
Hom.:
88
Bravo
AF:
0.0608
Asia WGS
AF:
0.0400
AC:
141
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
16
DANN
Benign
0.61
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41312901; hg19: chr9-123726029; API